Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down

BMC Genomics

Volumn 10, Issue , 2009, Pages 499-

  Costa, José L ^a,b   Eijk, Paul P ^a   van de Wiel, Mark A ^a,f   ten Berge, Derk ^c   Schmitt, Fernando ^b,d   Narvaez, Carmen J ^e   Welsh, JoEllen ^e   Ylstra, Bauke ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PORTO   (Portugal)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d University of Porto   (Portugal)

^e STATE UNIVERSITY OF NEW YORK   (United States)

^f VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CHROMOSOME 11Q; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 11; DRUG RESISTANCE, NEOPLASM; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; RECEPTORS, CALCITRIOL; RNA, SMALL INTERFERING; VITAMIN D;

EID: 70749144760     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-10-499     Document Type: Article

References (40)

1. Masuda S, Jones G. Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Molecular Cancer Therapeutics 2006, 5(4):797-808. 10.1158/1535-7163.MCT-05-0539, 16648549.
2. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nature Reviews in Cancer 2007, 7(9):684-700.
3. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. American Journal of Physiology - Renal Physiology 2005, 289(1):F8-28. 10.1152/ajprenal.00336.2004, 15951480.
4. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. Journal of Bone and Mineral Research 1998, 13(3):325-349. 10.1359/jbmr.1998.13.3.325, 9525333.
5. Norman AW, Mizwicki MT, Norman DP. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nature Reviews Drug Discovery 2004, 3(1):27-41. 10.1038/nrd1283, 14708019.
6. Gniadecki R. Nongenomic signaling by vitamin D: a new face of Src. Biochemical Pharmacology 1998, 56(10):1273-1277. 10.1016/S0006-2952(98)00182-8, 9825725.
7. Hansen CM, Rohde L, Madsen MW, Hansen D, Colston KW, Pirianov G, Holm PK, Binderup L. MCF-7/VD(R): a new vitamin D resistant cell line. Journal of Cell Biochemistry 2001, 82(3):422-436. 11500919, 10.1002/jcb.1162.
8. Narvaez CJ, VanWeelden K, Byrne I, Welsh J. Characterization of a vitamin D3-resistant MCF-7 cell line. Endocrinology 1996, 137(2):400-409. 10.1210/en.137.2.400, 8593782.
9. Byrne B, Welsh J. Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells. Journal of Steroid Biochemistry and Molecular Biology 2007, 103(3-5):703-707. 10.1016/j.jsbmb.2006.12.061, 1885398, 17254776.
10. Palmer HG, Sanchez-Carbayo M, Ordonez-Moran P, Larriba MJ, Cordon-Cardo C, Munoz A. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Research 2003, 63(22):7799-7806.
11. Swami S, Raghavachari N, Muller UR, Bao YP, Feldman D. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Research and Treatment 2003, 80(1):49-62. 10.1023/A:1024487118457, 12889598.
12. Towsend K, Trevino V, Falciani F, Stewart PM, Hewison M, Campbell MJ. Identification of VDR-responsive gene signatures in breast cancer cells. Oncology 2006, 71(1-2):111-123. 10.1159/000100989, 17377416.
13. Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B, Zhang R. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol 2005, 19(11):2685-2695. 10.1210/me.2005-0106, 16002434.
14. Peter R, Dirk P, Christian H, Yves C. A new, rapid colorimetric assay for quantitative determination of cellular proliferation, growth inhibition, and viability. Methods in Cell Science 1993, 15(1):37-41.
15. Ijssel P, Tijssen M, Chin SF, Eijk P, Carvalho B, Hopmans E, Holstege H, Bangarusamy DK, Jonkers J, Meijer GA. Human and mouse oligonucleotide-based array CGH. Nucleic Acids Research 2005, 33(22):e192. 10.1093/nar/gni191, 1316119, 16361265.
16. Muris JJ, Ylstra B, Cillessen SA, Ossenkoppele GJ, Kluin-Nelemans JC, Eijk PP, Nota B, Tijssen M, de Boer WP, Wiel M. Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas. British Journal of Haematology 2007, 136(1):38-47. 10.1111/j.1365-2141.2006.06375.x, 17062006.
17. Kerr MK, Martin M, Churchill GA. Analysis of variance for gene expression microarray data. Journal of Computational Biology 2000, 7(6):819-837. 10.1089/10665270050514954, 11382364.
18. Cho RJ, Campbell MJ. Transcription, genomes, function. Trends in Genetics 2000, 16(9):409-415. 10.1016/S0168-9525(00)02065-5, 10973070.
19. Huusko P, Ponciano-Jackson D, Wolf M, Kiefer JA, Azorsa DO, Tuzmen S, Weaver D, Robbins C, Moses T, Allinen M. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nature Genetics 2004, 36(9):979-983. 10.1038/ng1408, 15300251.
20. Jong K, Marchiori E, Meijer G, Vaart AV, Ylstra B. Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics 2004, 20(18):3636-3637. 10.1093/bioinformatics/bth355, 15201182.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
22. Chin SF, Wang Y, Thorne NP, Teschendorff AE, Pinder SE, Vias M, Naderi A, Roberts I, Barbosa-Morais NL, Garcia MJ. Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers. Oncogene 2007, 26(13):1959-1970. 10.1038/sj.onc.1209985, 17001317.
23. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL, Brown PO. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proceedings of the National Academy of Sciences 2002, 99(20):12963-12968. 12297621, 10.1073/pnas.162471999, 130569.
24. Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R, Dairkee S, Tokuyasu T, Ljung BM, Jain AN. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 2006, 6:96. 10.1186/1471-2407-6-96, 1459181, 16620391.
25. Climent J, Dimitrow P, Fridlyand J, Palacios J, Siebert R, Albertson DG, Gray JW, Pinkel D, Lluch A, Martinez-Climent JA. Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer. Cancer Research 2007, 67(2):818-826. 10.1158/0008-5472.CAN-06-3307, 17234794.
26. Wiel MA, Kim KI, Vosse SJ, van Wieringen WN, Wilting SM, Ylstra B. CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics 2007, 23(7):892-894. 10.1093/bioinformatics/btm030, 17267432.
27. Losel R, Wehling M. Nongenomic actions of steroid hormones. Nature Reviews Molecular Cell Biology 2003, 4(1):46-56. 10.1038/nrm1009, 12511868.
28. Ly LH, Zhao XY, Holloway L, Feldman D. Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology 1999, 140(5):2071-2076. 10.1210/en.140.5.2071, 10218956.
29. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW, Pinkel D. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genetics 2000, 25(2):144-146. 10.1038/75985, 10835626.
30. Costa JL, Meijer G, Ylstra B, Caldas C. Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies. Seminars in Radiation Oncology 2008, 18(2):98-104. 10.1016/j.semradonc.2007.10.005, 18314064.
31. Jong K, Marchiori E, Vaart A, Chin SF, Carvalho B, Tijssen M, Eijk PP, Ijssel P, Grabsch H, Quirke P. Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors. Oncogene 2007, 26(10):1499-1506. 10.1038/sj.onc.1209919, 16936777.
32. Wiel MA, Costa JL, Smid K, Oudejans CB, Bergman AM, Meijer GA, Peters GJ, Ylstra B. Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations. Cancer Research 2005, 65(22):10208-10213. 10.1158/0008-5472.CAN-05-0760, 16288008.
33. Buffart TE, Israeli D, Tijssen M, Vosse SJ, Mrsic A, Meijer GA, Ylstra B. Across array comparative genomic hybridization: A strategy to reduce reference channel hybridizations. Genes Chromosomes and Cancer 2008, 47(11):994-1004. 10.1002/gcc.20605, 18663753.
34. Taylor TD, Noguchi H, Totoki Y, Toyoda A, Kuroki Y, Dewar K, Lloyd C, Itoh T, Takeda T, Kim DW. Human chromosome 11 DNA sequence and analysis including novel gene identification. Nature 2006, 440(7083):497-500. 10.1038/nature04632, 16554811.
35. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes and Development 1996, 10(2):142-153. 10.1101/gad.10.2.142, 8566748.
36. Jiang F, Li P, Fornace AJ, Nicosia SV, Bai W. G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. Journal of Biological Chemistry 2003, 278(48):48030-48040. 10.1074/jbc.M308430200, 14506229.
37. Zinser GM, McEleney K, Welsh J. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice. Molecular and Cellular Endocrinology 2003, 200(1-2):67-80. 10.1016/S0303-7207(02)00416-1, 12644300.
38. Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, Wiel MA, van Criekinge W, Thas O, Matthai A, Cuesta MA. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 2009, 58(1):79-89. 10.1136/gut.2007.143065, 18829976.
39. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, Parsons DW, Jones S, Sjoblom T, Park BH, Parsons R. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proceedings of the National Academy of Sciences 2008, 105(42):16224-16229. 18852474, 10.1073/pnas.0808041105, 2571022.
40. Solomon C, Kremer R, White JH, Rhim JS. Vitamin D resistance in RAS-transformed keratinocytes: mechanism and reversal strategies. Radiation Research 2001, 155(1 Pt 2):156-162. 10.1667/0033-7587(2001)155[0156:VDRIRT]2.0.CO;2, 11121228.